...
Altalife 2023
Discovery range
Altalife 2023
A private equity portfolio available through French life insurance policies and PER .
Altalife closed on December 31, 2024.
Altalife closed on December 31, 2024.
Discover
Altalife 2023
Altalife , the first FCPR in the Discovery range, offers a diversified private equity portfolio comprising international funds and co-investments with no fees or carried interest in companies with strong growth potential.
With Altalife , Altaroc offers Altaroc both geographical and sector diversification with liquidity guaranteed by insurers.
With Altalife , Altaroc offers Altaroc both geographical and sector diversification with liquidity guaranteed by insurers.
Altalife 2023 key points
Marketing period
Until December 31, 2024
Duration
10 years
Eligibility
Eligible for French life insurance and PER Assurance
Legal form
An AMF-certified FCPR fund
Minimum subscription
Amount defined by the insurer
Classified
SFDR Article 8 fund
Performance-related commissions
20% only on co-investments
Management fees
2,5%
* The return is neither guaranteed nor contractual, and is merely a management objective. Investing in the Fund entails a risk of capital loss and illiquidity.
Investing in private equity involves risks
The Altalife 2023 offer is available to private clients through life insurance policies managed by leading French life insurers.
Private equity investments entail risks of liquidity and capital loss. To find out more about all the risks associated with private equity, visit our Private Equity Performance and Risks page.
Private equity investments entail risks of liquidity and capital loss. To find out more about all the risks associated with private equity, visit our Private Equity Performance and Risks page.
Insurers
An offer distributed by a large number of insurers
The FCPR Altalife provides access to a portfolio of global private equity funds—which are typically unavailable—through life insurance policies and retirement savings plans (PER).
Liquidity guaranteed at all times by the insurer,
100% of the FCPR fund is invested in Private Equity.
At Altaroc, we're delighted to be continuing our partnership with leading players.






Altalife 2023 portfolio
Target composition of the €500m Vintage
80% allocated to 2 global private equity managers
19% allocated to co-investments with managers selected for their track-record
managers






Co-investments
Fund
managers
2 selected global funds
Target
80% invested in two funds
The FCPR Altalife fund is invested in two funds:
Hg 4, a mid-market buyout fund buyout by Hg, Fund manager European Fund manager in the software sector.
Five Arrows Investment IV (“FAPIIV”), a mid-market buyout fund Fund manager byFive Arrows Rothschild), which invests in the software, healthcare, and business services sectors.
Both funds invest in Europe as well as in the United States, allocating 20–25% of their capital to U.S . investments.
Investing in private equity involves risks of capital loss and illiquidity. Past performance is not indicative of future results.
Hg 4, a mid-market buyout fund buyout by Hg, Fund manager European Fund manager in the software sector.
Five Arrows Investment IV (“FAPIIV”), a mid-market buyout fund Fund manager byFive Arrows Rothschild), which invests in the software, healthcare, and business services sectors.
Both funds invest in Europe as well as in the United States, allocating 20–25% of their capital to U.S . investments.
Investing in private equity involves risks of capital loss and illiquidity. Past performance is not indicative of future results.
Five Arrows
51.51230942868651, -0.08900576046054165
Five Arrows
the funds
Five Arrows Partners II
Five Arrows Principal Investors IV
15 €m
Disclosures regarding the manager
year of inception
2008
Offices
2
Assets under management
24 €bn
the team
+220 people

Hg
51.50535195689056, -0.08055042883579441

Hg
the funds
HG Capital Genesis 10
50 €m
HG Capital Saturn 3
52,4 €m
HG Mercury 4
15 €m
HG Saturn 4
$66 million
HG Mercury 5
25 €m
Disclosures regarding the manager
year of inception
1990
Offices
3
Assets under management
75 $bn
the team
+380 people
Co-investments
co-invesTmenT
4 co-investments made
Target
20% invested
The co-investment portion of the Altalife FCPR is invested in four companies:
Visma, a publisher of accounting, payroll and human resources management, operating in Europe and Latin America
Diapason, a leading French publisher of cash flow and risk management software for large and medium-sized companies
Evoriel (formerly Nexity ADB), a carve-out of the Nexity group's property management business in France.
Howden, a leading insurance brokerage group operating across the entire value chain (insurance, reinsurance, brokerage, consulting).
Private equity investments involve risks of capital loss and liquidity. Past performance is not indicative of future results.
Visma, a publisher of accounting, payroll and human resources management, operating in Europe and Latin America
Diapason, a leading French publisher of cash flow and risk management software for large and medium-sized companies
Evoriel (formerly Nexity ADB), a carve-out of the Nexity group's property management business in France.
Howden, a leading insurance brokerage group operating across the entire value chain (insurance, reinsurance, brokerage, consulting).
Private equity investments involve risks of capital loss and liquidity. Past performance is not indicative of future results.
By investing in Altalife, you'll be supporting the growth of promising small and medium-sized businesses in the sectors of the future.
Find out more about the French and international #Licornes that make up our portfolios. Discover also our companies in #HighGrowththat are disrupting their markets through #Innovative. Our portfolios are also built around companies that are #must-have companies you're bound to know, recognized for their #PositiveImpact on the world.
No items found.
How FCPR Altalife 2023 works
Minimum subscription amount
The insurer determines the minimum subscription amount within the life insurance contract
Cash liquidity
The client may decide to sell Discovery shares at any time. The shares will be redeemed by the insurer at their net asset value.
Net asset value
The value of the client's shares is determined by the insurer, who receives the portfolio's net asset value from Altaroc every two months.
Newsroom
All the latest news on the Altalife 2023 venture capital fund
Newsletter
Don’t miss any of our news – sign up for our newsletter
Documentation
Altalife 2023 documentation
Regulatory documentation
Altaroc Altalife 2023 - Disclosure Article 8 (SFDR compliance)
For any requests to access additional documents from the collection or documentation available in other languages, please contact our partner service.
FAQs
K1 Management
Vitruvian
Thoma Bravo
Summit Partners
New Mountain Capital
Inflexion
Main Capital
Cressey & Company
TA Associates
STG
Accel-KKR
Five Arrows
Seven2
Nordic Capital
Hg
Insight Partners
Apax
CVC
General Atlantic
Bridgepoint











.jpeg)


















.webp)

















































.webp)



















.png)






